Prognostic Significance of Initial Platelet Counts and Fibrinogen Level in Advanced Non-Small Cell Lung Cancer.
10.3346/jkms.2014.29.4.507
- Author:
Kyung Hee KIM
1
;
Tae Yun PARK
;
Ji Yeun LEE
;
Sang Min LEE
;
Jae Joon YIM
;
Chul Gyu YOO
;
Young Whan KIM
;
Sung Koo HAN
;
Seok Chul YANG
Author Information
1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine, Seoul, Korea. scyang@snu.ac.kr
- Publication Type:Original Article
- Keywords:
Carcinoma Non-Small Cell Lung;
Prognosis;
Thrombocytosis;
Fibrinogen
- MeSH:
Aged;
Blood Platelets/*cytology;
Carcinoma, Non-Small-Cell Lung/*diagnosis/mortality/pathology;
Female;
Fibrinogen/*analysis;
Humans;
Lung Neoplasms/*diagnosis/mortality/pathology;
Male;
Middle Aged;
Neoplasm Staging;
Platelet Count;
Prognosis;
Retrospective Studies;
Survival Rate;
Thrombocytosis/complications/diagnosis
- From:Journal of Korean Medical Science
2014;29(4):507-511
- CountryRepublic of Korea
- Language:English
-
Abstract:
Thrombocytosis and coagulation systems activation are commonly associated with disease progression and are suggested poor prognostic factors in patients with malignancies. This study aimed to investigate the prevalence and prognostic significance of thrombocytosis and elevated fibrinogen levels in patients with advanced non-small cell lung cancer (NSCLC). Initial platelet counts and fibrinogen levels were reviewed in 854 patients with histologically proven NSCLC. Thrombocytosis was defined as platelet counts > 450 x 10(9)/L. A serum fibrinogen level > 4.5 g/L was considered high. At the time of diagnosis, initial platelet counts and serum fibrinogen levels were evaluated before treatment. Clinicopathologic data including histological type, tumor, node, metastasis (TNM) stage, performance status, treatment method, and survival time were evaluated. Initial thrombocytosis was found in 6.9% of patients, and elevated fibrinogen levels were found in 55.1% of patients. Patients with thrombocytosis had a significantly poorer prognosis than patients with normal platelet counts (P < 0.001). In multivariate survival analysis, thrombocytosis was an independent prognostic factor (P < 0.001). An elevated serum fibrinogen level was associated with poor prognosis (P < 0.001). In conclusion, initial thrombocytosis and a high fibrinogen level are independent factors for predicting poor prognosis in patients with advanced NSCLC.
